{"id":541076,"date":"2021-09-22T09:08:10","date_gmt":"2021-09-22T13:08:10","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/clarus-therapeutics-to-present-at-the-2021-cantor-virtual-global-healthcare-conference\/"},"modified":"2021-09-22T09:08:10","modified_gmt":"2021-09-22T13:08:10","slug":"clarus-therapeutics-to-present-at-the-2021-cantor-virtual-global-healthcare-conference","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/clarus-therapeutics-to-present-at-the-2021-cantor-virtual-global-healthcare-conference\/","title":{"rendered":"Clarus Therapeutics to Present at the 2021 Cantor Virtual Global Healthcare Conference"},"content":{"rendered":"<div class=\"mw_release\">\n<p>NORTHBROOK, Ill., Sept.  22, 2021  (GLOBE NEWSWIRE) &#8212; Clarus Therapeutics Holdings, Inc. (Nasdaq:CRXT), a pharmaceutical company dedicated to providing solutions to unmet medical needs by advancing androgen and metabolic therapies for men and women, today announced that it will present at the 2021 Cantor Virtual Global Healthcare Conference, Monday, September 27, 2021, 10:40 a.m. ET.<\/p>\n<p>The presentation will be webcast live and can be accessed through the Investors section of Clarus Therapeutics\u2019 website at\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=uiLDa8chKR8sj5SBriACjvvoLpoMmlcfTorDV48oJ4mReDQK2Gkct-Na2TdT5O4DWsTfo0d4WQF8ncEdYlrJyYKvcFd52WIyPue0geVdl36G0GjgfsktueU047tXwo96\" rel=\"nofollow noopener\" target=\"_blank\">Investors.ClarusTherapeutics.com<\/a>. An archived version of the webcast will be available approximately two hours following the live presentation for 90 days.<\/p>\n<p>\n        <strong>About Clarus Therapeutics Holdings, Inc. <\/strong><br \/>\n        <br \/>Clarus Therapeutics Holdings, Inc. is a pharmaceutical company with expertise in developing androgen and metabolic therapies for men and women \u2013 including potential therapies for orphan indications. Clarus Therapeutics\u2019 first commercial product is JATENZO\u00ae. For more information, visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=9GzKrC9becNojNYl2ETfMo5G36fKH_rs8msHS73z6lzAtLj5JhQrk_hn-Kl2tZx4TrrBiVMesuZq63p5u82-aef3v6ZBDzHHYYVKVcKPrUqyn1X3pb1sN9Hh_u3NjnSJ\" rel=\"nofollow noopener\" target=\"_blank\">www.clarustherapeutics.com<\/a>\u00a0and <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=7nsJvAGukzjPyNDkgDed-jPABKBSVXHW1hw8UfN-ZASeDcalFxEWMUTabdFGM-dKjm0xt5P8WHsz51qSs2IqhQ==\" rel=\"nofollow noopener\" target=\"_blank\">www.jatenzo.com<\/a>. Follow us on Twitter (<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=EH35ugn-vSVFhrQItpxh_7NkWVxrptMKkrRJQzSAygM694eQHm9ZqO2hX1SXRKEpOtZ7HlwBGN5w-8AUq7gWf1cxYc2Lg9wmG9xDAStJZGw=\" rel=\"nofollow noopener\" target=\"_blank\">@Clarus_Thera<\/a>) and LinkedIn (<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=wNguPhxMo7AJd7jtOIBI0YYrZ4vxOJoG716e9jh6iLV4IrzjTYsIEmGPfXEbns86_ilx0jcyAXuSvrOZqINTMgOOALk1sjGOAI_4Zf_0_7oluh-RT1slx4SR1ak34ZT8\" rel=\"nofollow noopener\" target=\"_blank\">Clarus Therapeutics<\/a>).<\/p>\n<p>\n        <strong>Clarus Investor Relations Contact:<\/strong><br \/>\n        <br \/>Kara Stancell<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=YLR_M4ISKGql_KUjEZyU_jP93kzh4FzcaLRZFIz2ljKOEC6o6K_A0l8tJy6rn-Ylxwwc7_PblX4lNZCCSZsWMGgGAQji-H6bEkIMOTi0MkrpfpP9cpDPUvPnSOeIEsrN\" rel=\"nofollow noopener\" target=\"_blank\">kstancell@clarustherapeutics.com<\/a><br \/>(847) 562-4300 x 206<\/p>\n<p>\u00a0<\/p>\n<p>      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMzMDAyNiM0NDE0OTYxIzIwMDc0ODc=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/YjYyYmNmYTItZTMzYi00ZWJhLWJkYTQtYTIwZDQ1NWNhNTQ4LTEwMTkwNjA=\/tiny\/Clarus-Therapeutics-Holdings-I.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>NORTHBROOK, Ill., Sept. 22, 2021 (GLOBE NEWSWIRE) &#8212; Clarus Therapeutics Holdings, Inc. (Nasdaq:CRXT), a pharmaceutical company dedicated to providing solutions to unmet medical needs by advancing androgen and metabolic therapies for men and women, today announced that it will present at the 2021 Cantor Virtual Global Healthcare Conference, Monday, September 27, 2021, 10:40 a.m. ET. The presentation will be webcast live and can be accessed through the Investors section of Clarus Therapeutics\u2019 website at\u00a0Investors.ClarusTherapeutics.com. An archived version of the webcast will be available approximately two hours following the live presentation for 90 days. About Clarus Therapeutics Holdings, Inc. Clarus Therapeutics Holdings, Inc. is a pharmaceutical company with expertise in developing androgen and metabolic therapies for men and women \u2013 including &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/clarus-therapeutics-to-present-at-the-2021-cantor-virtual-global-healthcare-conference\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Clarus Therapeutics to Present at the 2021 Cantor Virtual Global Healthcare Conference&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-541076","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Clarus Therapeutics to Present at the 2021 Cantor Virtual Global Healthcare Conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/clarus-therapeutics-to-present-at-the-2021-cantor-virtual-global-healthcare-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Clarus Therapeutics to Present at the 2021 Cantor Virtual Global Healthcare Conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"NORTHBROOK, Ill., Sept. 22, 2021 (GLOBE NEWSWIRE) &#8212; Clarus Therapeutics Holdings, Inc. (Nasdaq:CRXT), a pharmaceutical company dedicated to providing solutions to unmet medical needs by advancing androgen and metabolic therapies for men and women, today announced that it will present at the 2021 Cantor Virtual Global Healthcare Conference, Monday, September 27, 2021, 10:40 a.m. ET. The presentation will be webcast live and can be accessed through the Investors section of Clarus Therapeutics\u2019 website at\u00a0Investors.ClarusTherapeutics.com. An archived version of the webcast will be available approximately two hours following the live presentation for 90 days. About Clarus Therapeutics Holdings, Inc. Clarus Therapeutics Holdings, Inc. is a pharmaceutical company with expertise in developing androgen and metabolic therapies for men and women \u2013 including &hellip; Continue reading &quot;Clarus Therapeutics to Present at the 2021 Cantor Virtual Global Healthcare Conference&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/clarus-therapeutics-to-present-at-the-2021-cantor-virtual-global-healthcare-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-09-22T13:08:10+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMzMDAyNiM0NDE0OTYxIzIwMDc0ODc=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/clarus-therapeutics-to-present-at-the-2021-cantor-virtual-global-healthcare-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/clarus-therapeutics-to-present-at-the-2021-cantor-virtual-global-healthcare-conference\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Clarus Therapeutics to Present at the 2021 Cantor Virtual Global Healthcare Conference\",\"datePublished\":\"2021-09-22T13:08:10+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/clarus-therapeutics-to-present-at-the-2021-cantor-virtual-global-healthcare-conference\\\/\"},\"wordCount\":172,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/clarus-therapeutics-to-present-at-the-2021-cantor-virtual-global-healthcare-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMzMDAyNiM0NDE0OTYxIzIwMDc0ODc=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/clarus-therapeutics-to-present-at-the-2021-cantor-virtual-global-healthcare-conference\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/clarus-therapeutics-to-present-at-the-2021-cantor-virtual-global-healthcare-conference\\\/\",\"name\":\"Clarus Therapeutics to Present at the 2021 Cantor Virtual Global Healthcare Conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/clarus-therapeutics-to-present-at-the-2021-cantor-virtual-global-healthcare-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/clarus-therapeutics-to-present-at-the-2021-cantor-virtual-global-healthcare-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMzMDAyNiM0NDE0OTYxIzIwMDc0ODc=\",\"datePublished\":\"2021-09-22T13:08:10+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/clarus-therapeutics-to-present-at-the-2021-cantor-virtual-global-healthcare-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/clarus-therapeutics-to-present-at-the-2021-cantor-virtual-global-healthcare-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/clarus-therapeutics-to-present-at-the-2021-cantor-virtual-global-healthcare-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMzMDAyNiM0NDE0OTYxIzIwMDc0ODc=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMzMDAyNiM0NDE0OTYxIzIwMDc0ODc=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/clarus-therapeutics-to-present-at-the-2021-cantor-virtual-global-healthcare-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Clarus Therapeutics to Present at the 2021 Cantor Virtual Global Healthcare Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Clarus Therapeutics to Present at the 2021 Cantor Virtual Global Healthcare Conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/clarus-therapeutics-to-present-at-the-2021-cantor-virtual-global-healthcare-conference\/","og_locale":"en_US","og_type":"article","og_title":"Clarus Therapeutics to Present at the 2021 Cantor Virtual Global Healthcare Conference - Market Newsdesk","og_description":"NORTHBROOK, Ill., Sept. 22, 2021 (GLOBE NEWSWIRE) &#8212; Clarus Therapeutics Holdings, Inc. (Nasdaq:CRXT), a pharmaceutical company dedicated to providing solutions to unmet medical needs by advancing androgen and metabolic therapies for men and women, today announced that it will present at the 2021 Cantor Virtual Global Healthcare Conference, Monday, September 27, 2021, 10:40 a.m. ET. The presentation will be webcast live and can be accessed through the Investors section of Clarus Therapeutics\u2019 website at\u00a0Investors.ClarusTherapeutics.com. An archived version of the webcast will be available approximately two hours following the live presentation for 90 days. About Clarus Therapeutics Holdings, Inc. Clarus Therapeutics Holdings, Inc. is a pharmaceutical company with expertise in developing androgen and metabolic therapies for men and women \u2013 including &hellip; Continue reading \"Clarus Therapeutics to Present at the 2021 Cantor Virtual Global Healthcare Conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/clarus-therapeutics-to-present-at-the-2021-cantor-virtual-global-healthcare-conference\/","og_site_name":"Market Newsdesk","article_published_time":"2021-09-22T13:08:10+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMzMDAyNiM0NDE0OTYxIzIwMDc0ODc=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/clarus-therapeutics-to-present-at-the-2021-cantor-virtual-global-healthcare-conference\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/clarus-therapeutics-to-present-at-the-2021-cantor-virtual-global-healthcare-conference\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Clarus Therapeutics to Present at the 2021 Cantor Virtual Global Healthcare Conference","datePublished":"2021-09-22T13:08:10+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/clarus-therapeutics-to-present-at-the-2021-cantor-virtual-global-healthcare-conference\/"},"wordCount":172,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/clarus-therapeutics-to-present-at-the-2021-cantor-virtual-global-healthcare-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMzMDAyNiM0NDE0OTYxIzIwMDc0ODc=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/clarus-therapeutics-to-present-at-the-2021-cantor-virtual-global-healthcare-conference\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/clarus-therapeutics-to-present-at-the-2021-cantor-virtual-global-healthcare-conference\/","name":"Clarus Therapeutics to Present at the 2021 Cantor Virtual Global Healthcare Conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/clarus-therapeutics-to-present-at-the-2021-cantor-virtual-global-healthcare-conference\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/clarus-therapeutics-to-present-at-the-2021-cantor-virtual-global-healthcare-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMzMDAyNiM0NDE0OTYxIzIwMDc0ODc=","datePublished":"2021-09-22T13:08:10+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/clarus-therapeutics-to-present-at-the-2021-cantor-virtual-global-healthcare-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/clarus-therapeutics-to-present-at-the-2021-cantor-virtual-global-healthcare-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/clarus-therapeutics-to-present-at-the-2021-cantor-virtual-global-healthcare-conference\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMzMDAyNiM0NDE0OTYxIzIwMDc0ODc=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMzMDAyNiM0NDE0OTYxIzIwMDc0ODc="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/clarus-therapeutics-to-present-at-the-2021-cantor-virtual-global-healthcare-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Clarus Therapeutics to Present at the 2021 Cantor Virtual Global Healthcare Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/541076","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=541076"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/541076\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=541076"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=541076"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=541076"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}